Company research / VNDA
Vanda Pharmaceuticals Inc. (VNDA)
- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
For the year ended 2025-12-31, Vanda Pharmaceuticals Inc. reported revenue of $216.10M. Revenue grew 8.7% from the prior annual period.
Key ratios (year ended 2025-12-31)
-70.0%
Operating margin
-102.0%
Net margin
-67.4%
Return on year-end equity
8.7%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.